The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Hepatocytes direct the formation of a pro-metastatic niche in the liver
Open accessAbstract
The liver is the most common site of metastatic disease 1. Although this metastatic tropism may reflect the mechanical trapping of circulating tumour cells, liver metastasis is also dependent, at least in part, on the formation of a 'pro-metastatic' niche that supports the spread of tumour cells to the liver 2,3. The mechanisms that direct the formation of this niche are poorly understood. Here we show that hepatocytes coordinate myeloid cell accumulation and fibrosis within the liver and, in doing so, increase the susceptibility of the liver to metastatic seeding and outgrowth. During early pancreatic tumorigenesis in mice, hepatocytes show activation of signal transducer and activator of transcription 3 (STAT3) signalling and increased production of serum amyloid A1 and A2 (referred to collectively as SAA). Overexpression of SAA by hepatocytes also occurs in patients with pancreatic and colorectal cancers that have metastasized to the liver, and many patients with locally advanced and metastatic disease show increases in circulating SAA. Activation of STAT3 in hepatocytes and the subsequent production of SAA depend on the release of interleukin 6 (IL-6) into the circulation by non-malignant cells. Genetic ablation or blockade of components of IL-6-STAT3-SAA signalling prevents the establishment of a pro-metastatic niche and inhibits liver metastasis. Our data identify an intercellular network underpinned by hepatocytes that forms the basis of a pro-metastatic niche in the liver, and identify new therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Markedly, in mouse fetal livers, STAT3 was not activated (Figure S6D) and canonical STAT3 target genes 31,32 were not induced (Figure S6E).”
From Kupffer-cell-derived IL-6 is repurposed for hepatocyte dedifferentiation via activating progenitor genes from injury-specific enhancers (2023) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Primer3—new capabilities and interfaces
Untergasser, A., Cutcutache, I., Kõressaar, T., Ye, J., Faircloth, B., Remm, M., & Rozen, S. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks596 · Cited by 9,165
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Bindea, G., Mlecnik, B., Hackl, H., Charoentong, P., Tosolini, M., Kirilovsky, A., Fridman, W.-H., Pagès, F., Trajanoski, Z., & Galon, J. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp101 · Cited by 6,280
Tumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Costa-Silva, B., Aiello, N. M., Ocean, A. J., Singh, S., Zhang, H., Thakur, B. K., Becker, A., Hoshino, A., Mark, M. T., Molina, H., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3169 · Cited by 2,692
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Hidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570
Cited by
Sorted by citations
Items 201–300 of 410
TRIM21-mediated ubiquitylation of TAT suppresses liver metastasis in gallbladder cancer
Wu, Z.-Y., Zhang, J., Jia, Z., Yang, Z., Liu, S., Wang, H., Zhao, C., Zhao, J., Tang, Q., Xiong, Y., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216923 · Cited by 17
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy
Chen, C., Han, P., & Qing, Y. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103579 · Cited by 17
Tang, J., Zhang, J., Zhang, G., Peng, W., Ling, N., Zhou, Y., Xu, H., Ren, H., & Chen, M. (2024) · mBio · doi:10.1128/mbio.03068-23 · Cited by 16
Towards understanding cancer dormancy over strategic hitching up mechanisms to technologies
Yang, S., Seo, J., Choi, J., Kim, S.-H., Kuk, Y., Park, K. C., Kang, M., Byun, S., & Joo, J. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02250-9 · Cited by 20
Liver prometastatic reaction: Stimulating factors and responsive cancer phenotypes
Vidal‐Vanaclocha, F., Crende, O., de Durango, C. G., Herreros‐Pomares, A., López‐Domènech, S., González, Á., Ruiz-Casares, E., Vilboux, T., Caruso, R. R. C., Durán, H. J., et al. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.08.001 · Cited by 16
Meltzer, S., Torgunrud, A., Abrahamsson, H., Solbakken, A. M., Flatmark, K., Dueland, S., Bakke, K. M., Bousquet, P. A., Negård, A., Johansen, C., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01377-y · Cited by 17
Diskin, B. E., Adam, S., Soto, G. S., Liria, M., Aykut, B., Sundberg, B., Li, E. H., Leinwand, J., Chen, R., Kim, M., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02425-4 · Cited by 16
Krebs, N., Klein, L., Wegwitz, F., Espinet, E., Maurer, H. C., Tu, M., Penz, F., Küffer, S., Xu, X., Bohnenberger, H., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.154475 · Cited by 16
Liver Microenvironment Response to Prostate Cancer Metastasis and Hormonal Therapy
Buxton, A. K., Abbasova, S., Bevan, C. L., & Leach, D. A. (2022) · Cancers · doi:10.3390/cancers14246189 · Cited by 17
The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy
Tufail, M., Gong, K., Ijaz, B., Patel, H. H., Lui, W., Wang, X., & Li, J. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101355 · Cited by 16
Self-citationDecoding the obesity–cancer connection: lessons from preclinical models of pancreatic adenocarcinoma
Ruiz, C. F., Garcia, C. C., Jacox, J. B., Lawres, L., & Muzumdar, M. D. (2023) · Life Science Alliance · doi:10.26508/lsa.202302228 · Cited by 17
Xiang, J., Zhang, N., Du, A., Li, J., Luo, M., Wang, Y., Liu, M., Yang, L., Li, X., Wang, L., et al. (2023) · Advanced Science · doi:10.1002/advs.202305550 · Cited by 15
Self-citationThe two facets of gp130 signalling in liver tumorigenesis
Schmidt‐Arras, D., Galun, E., & Rose‐John, S. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00861-0 · Cited by 15
Jiang, S.-H., Liu, D., Hu, L.-P., Zhang, S., Yu, Y., Sun, Y., Ji, J., & Zhang, Z. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104050 · Cited by 15
Self-citationIL-6 drives niche formation in pancreatic cancer liver metastasis
Thomas, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0138-6 · Cited by 14
Shi, X., Zhu, W., Zhang, J., Fan, C., & Zhang, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1620075 · Cited by 13
Hu, H., Yang, M., Baoyou, H., Ding, J., Zhu, Y., Xu, X., Yin, B., Zhou, H., Huang, T., Li, M., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03536-y · Cited by 13
Gan, C., Wang, J., Wang, Y., Martínez-Chávez, A., Hillebrand, M. J. X., de Vries, N., Beukers, J., Lebre, M. C., Wagenaar, E., Rosing, H., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114956 · Cited by 13
Cancer-Associated Fibroblasts: From Spectators to Protagonists in Pancreatic Cancer Progression
Mucciolo, G., Li, W., & Biffi, G. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-2448 · Cited by 13
Off-target effects of CRISPRa on interleukin-6 expression
Soubeyrand, S., Lau, P., Peters, V., & McPherson, R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224113 · Cited by 13
Immune Milieu Established by Postpartum Liver Involution Promotes Breast Cancer Liver Metastasis
Bartlett, A. Q., Pennock, N. D., Klug, A., & Schedin, P. S. (2021) · Cancers · doi:10.3390/cancers13071698 · Cited by 13
Peisl, S., Mellenthin, C., Vignot, L., Gonelle‐Gispert, C., Bühler, L., & Egger, B. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252397 · Cited by 13
Heterocellular crosstalk and architecture of the pancreatic tumour microenvironment
Arnold, F., Vecchio, A. D., Hussain, Z., & Sherman, M. H. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-025-00905-9 · Cited by 15
Beatty, G. L., Delman, D., Yu, J., Liu, M., Li, J. H., Zhang, L., Lee, J. W., Chang, R. B., Bahary, N., Kennedy, E. P., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0535 · Cited by 13
Self-citationCell competition promotes metastatic intestinal cancer through a multistage process
García, A. K., Ledesma-Terrón, M., Λάμπρου, Μ., Vriend, J., van Luyk, M. E., & Suijkerbuijk, S. J. E. (2024) · iScience · doi:10.1016/j.isci.2024.109718 · Cited by 13
Dysadherin awakens mechanical forces and promotes colorectal cancer progression
Park, S., Lee, C.-J., Choi, J.-H., Kim, J., Lee, W.-J., Jang, T., Jeon, S.-E., Kim, J., Cho, S., Lee, J. S., et al. (2022) · Theranostics · doi:10.7150/thno.72354 · Cited by 12
Self-citationLi, F., Song, X., Zhou, X., Chen, L., & Zheng, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17052 · Cited by 12
Snyder, C. M., & Gill, S. I. (2023) · Immunological Reviews · doi:10.1111/imr.13231 · Cited by 12
Li, Z., Ma, L., Chen, M., Chen, X., Sha, M., & Hang, H. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2024.101275 · Cited by 11
Inflammation and Immunity in Liver Neoplasms: Implications for Future Therapeutic Strategies
Kim, J., & Seki, E. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0726 · Cited by 11
Gu, Y., Mi, Y., Cao, Y., Yu, K., Zhang, Z., Lian, P., Li, D., Qin, J., & Zhao, S. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01365-2 · Cited by 13
TNF blockade uncouples toxicity from antitumor efficacy induced with CD40 chemoimmunotherapy
Stone, M. L., Lee, J., Herrera, V. M., Graham, K. L., Lee, J. W., Huffman, A. P., Coho, H., Tooker, E., Myers, M. I., Giannone, M. A., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.146314 · Cited by 14
Self-citationThe Etiology and Impact of Muscle Wasting in Metastatic CancerPreprint
Biswas, A., & Acharyya, S. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037416 · Cited by 11
Minegishi, M., Kuchimaru, T., Nishikawa, K., Isagawa, T., Iwano, S., Iida, K., Hara, H., Miura, S., Sato, M., Watanabe, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43855-2 · Cited by 10
Cancer of unknown primary and the «seed and soil» hypothesis
Zolotykh, M. A., Mingazova, L. A., Викторовна, Ф. Ю., Blatt, N. L., Nesterova, A. I., Sabirov, A., Rizvanov, A. A., & Рифкатовна, М. Р. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104297 · Cited by 10
Li, D., Chu, X., Ma, Y., Zhang, F., Tian, X., Yang, Y., & Yang, Y. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217403 · Cited by 11
The multi-faceted roles of cancer-associated fibroblasts in pancreatic cancer
Kwon, J. Y., Vera, R. E., & Fernández-Zapico, M. E. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111584 · Cited by 10
Ose, J., Gigic, B., Hardikar, S. S., Lin, T., Himbert, C., Warby, C. A., Peoples, A. R., Lindley, C. L., Boehm, J., Schrotz‐King, P., et al. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0092 · Cited by 10
Videmark, A. N., Christensen, I. J., Feltoft, C. L., Villadsen, M., Borg, F. H., Jørgensen, B. M., Bojesen, S. E., Kistorp, C., Ugleholdt, R., & Johansen, J. S. (2022) · Cancer Medicine · doi:10.1002/cam4.5455 · Cited by 10
Zhao, Y., Chen, Y., Wan, Q., Xiao, C., Guo, Z., Du, X., Hu, Y. P., Zheng, A., & Cao, Z. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05296-8 · Cited by 10
Baer, J. M., Zuo, C., Kang, L., de la Lastra, A. A., Borcherding, N. C., Knolhoff, B. L., Bogner, S. J., Zhu, Y., Lewis, M. A., Zhang, N., et al. (2022) · SSRN Electronic Journal · doi:10.1101/2022.02.09.479745 · Cited by 10
Cell free RNA detection of pancreatic cancer in pre diagnostic high risk and symptomatic patients
Moore, T. W., Spiliotopoulos, E., Callahan, R. L., Kirschbaum, C. W., Bailey, C., Kim, H. J., Roskams-Hieter, B., Goncalves, F., Keith, D., Grossberg, A. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62685-y · Cited by 9
Harryvan, T. J., Abudukelimu, S., Stouten, I., van der Wel, E. J., Janson, S. G. T., Lenos, K., Lannagan, T. R. M., White, M., Sansom, O. J., Verdegaal, E. M. E., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113696 · Cited by 11
Fibroblast STAT3 Activation Drives Organ-Specific Premetastatic Niche Formation
Opsahl, E. L. L., Espinoza, C. E., Olivei, A. C., Okoye, J. O., Watkoske, H. R., Hoffman, M. T., Avritt, F. R., Elhossiny, A. M., Bischoff, A. C., Donahue, K. L., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-3472 · Cited by 9
Self-citationDeciphering the liver’s role in pancreatic cancer metastasis: pathways and therapeutic approaches
Inzunza, J., & del Valle, A. C. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-01202-2 · Cited by 11
Aberrant transcription factors in the cancers of the pancreas
Uddin, M. H., Al-Hallak, M. N., Philip, P. A., Chen, H., El‐Rayes, B. F., & Azmi, A. S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.08.011 · Cited by 9
Zhang, T., Dong, X., Zhou, Y., Liu, M., Hang, J., & Wu, L. (2021) · Cancer Biomarkers · doi:10.3233/cbm-210190 · Cited by 9
Diab, M., & El‐Rayes, B. F. (2022) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2022.60 · Cited by 10
Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer
Digomann, D., Heiduk, M., Reiche, C., Glück, J., Kahlert, C., Mirtschink, P., Klimová, A., Bösch, F., Tonn, T., Gaedcke, J., et al. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00459-9 · Cited by 9
Colorectal Liver Metastasis: Can Cytokines Make the Difference?
Ballarò, C., Quaranta, V., & Giannelli, G. (2023) · Cancers · doi:10.3390/cancers15225359 · Cited by 8
Zhu, L., Yu, X., Tang, X., Hu, C., Wu, L., Liu, Y., & Zhou, Q. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002981 · Cited by 8
Zhang, F., Cui, K., Zhou, Y., Niu, B., Zhao, S., Zhao, S., Liu, X., Shi, T., Kong, L., Yang, C., et al. (2025) · Nano Today · doi:10.1016/j.nantod.2025.102678 · Cited by 8
Serum Amyloid A: A Double-Edged Sword in Health and Disease
Ji, A., Meredith, L. W., & Shridas, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104528 · Cited by 8
Self-citationWang, W., Yi, Z., Yang, Z., Huang, Y., Chen, H., Li, Y., Jing, L., Yin, S., & Zhang, F. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07376-4 · Cited by 10
Huang, Y., Wang, Y., Zheng, T., Nie, S., Wang, Y., Shen, H., & Mo, F. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s464788 · Cited by 8
IL-6 trans-Signaling Regulates Neutrophilic Inflammation in Alcohol-Associated Hepatitis
Sarode, G. V., Hsu, M.-F., Haj, F. G., Barace, S., Argemí, J., Liu, M., Pandita, P., Cao, S., Shah, V. H., Gui, D., et al. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.05.023 · Cited by 7
N6-methyladenosine-dependent signaling in colorectal cancer: Functions and clinical potential
Liu, S., Liu, M., Li, Y., & Song, Q. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104360 · Cited by 9
Adaptation to MOMP drives cancer persistence
Guilbaud, E., & Galluzzi, L. (2022) · Cell Research · doi:10.1038/s41422-022-00729-4 · Cited by 8
Mehdizadeh, R., Ansari, A. M., Forouzesh, F., Ghadirian, R., Shahriari, F., Shariatpanahi, S. P., & Javidi, M. A. (2023) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2023.06.003 · Cited by 7
Targeted Lung Premetastasis Niche: Mechanisms, Strategies, and Application
Cao, C., Lu, D., Li, H., Shen, P., Zhuo, J., Lin, Z., He, C., Zhang, P., Ying, S., Wei, X., et al. (2025) · MedComm · doi:10.1002/mco2.70248 · Cited by 6
Qiao, Y., Yin, H., Zhang, Y., Zhang, J., & Dong, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1585858 · Cited by 8
Greene, E. R., Horvat, N. K., Doxie, D. B., Parihar, V. C., Kim, J., Herting, C. J., Grundy, E. E., Ruffin, A. T., Krasinskas, A. M., Maithel, S. K., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-1697 · Cited by 6
Inhibitory effect of non-alcoholic steatohepatitis on colon cancer liver metastasis
Yamada, S., Morine, Y., Ikemoto, T., Saito, Y., Miyazaki, K., Ichimura‐Shimizu, M., Tsuneyama, K., & Shimada, M. (2022) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2022.11.002 · Cited by 6
Zhu, Q., Wang, Y., Xu, L., Shi, M., Meng, Y., Shao, C., Lu, Y., He, Y., Huang, J., Li, X., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae596 · Cited by 5
Keep It Moving: Physical Activity in the Prevention of Obesity-Driven Pancreatic Cancer
Sogunro, A., & Muzumdar, M. D. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-1474 · Cited by 6
A Unique Signature for Cancer‐Associated Fibroblasts in Melanoma Metastases
Tauch, S., Hey, J., Kast, B., Gengenbacher, N., Weiß, L., Sator‐Schmitt, M., Lohr, S., Brobeil, A., Schirmacher, P., Utikal, J. S., et al. (2025) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.70002 · Cited by 6
Waldron, R. T., Wang, R., Shishido, S. N., Lugea, A., Ibrahim, A. G.-E., Mason, J. M., Ayres, M., Parker, S. J., Eyk, J. E. V., Lo, S. K., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217546 · Cited by 6
Niraparib-induced STAT3 inhibition increases its antitumor effects
Zhao, Q., Kohut, A. Y., Li, Y., Martincuks, A., Austria, T., Zhang, C., Santiago, N. L., Borrero, R. M., Phan, X. T., Melstrom, L. G., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.966492 · Cited by 7
Deletion of mTOR in liver epithelial cells enhances hepatic metastasis of colon cancer
Jiao, L. R., Eickhoff, R., Egners, A., Jumpertz, S., Roth, J., Erdem, M., Kroh, A., Duimel, H., López‐Iglesias, C., Caro, P., et al. (2021) · The Journal of Pathology · doi:10.1002/path.5768 · Cited by 6
Franco, A., Duryea, J., & McDonald, O. G. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10116-z · Cited by 5
Cells tagged near an early spread of cancer
Asselin-Labat, M.-L. (2019) · Nature · doi:10.1038/d41586-019-02399-6 · Cited by 6
Stone, M. L., Herrera, V. M., Li, Y., Coho, H., Xue, Y., Graham, K. K., Ratmansky, J., Delman, D., O’Brien, S., & Beatty, G. L. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-25-0575 · Cited by 5
Self-citationCunanan, C. J., Sanders, A. B., Gallant, K. C., Seedor, R. S., & Hartsough, E. J. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10298-8 · Cited by 5
Costamagna, A., Noemi, G., & Martini, M. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1726581 · Cited by 7
Zhang, X., Huang, N., Mu, Y., Chen, H., Zhu, M., Zhang, S., Liu, P., Zhang, H., Deng, H., Feng, K., et al. (2024) · Advanced Science · doi:10.1002/advs.202401127 · Cited by 6
Tsang, E. S., & Tempero, M. A. (2021) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2021.22 · Cited by 5
Hepatic iNKT cells facilitate colorectal cancer metastasis by inducing a fibrotic niche in the liver
Nater, M., Brügger, M. D., Cecconi, V., Pereira, P., Forni, G., Köksal, H., Dimakou, D., Herbst, M., Calvanese, A. L., Lucchiari, G., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112364 · Cited by 6
Zhong, Q., Zhong, Q., Cai, X., & Wu, R. (2023) · Genes & Genomics · doi:10.1007/s13258-023-01413-6 · Cited by 5
Wang, X., Li, Q., Lyu, Z., & Wu, Y. (2025) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b25-00008 · Cited by 5
Li, L., Zhao, L., Cao, K., Zhang, P., Xu, G., Zheng, J., Lin, Z., Yu, D., Ren, J., Zhang, J., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69250-1 · Cited by 4
Nutt, M. J., Yee, Y. S., Buyan, A., Andrewartha, N., Corry, B., Yeoh, G. C., & Stewart, S. G. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113353 · Cited by 4
Luo, Q., Liu, J., Fu, Q., Zhang, X., Yu, P., Liu, P., Zhang, J., Tian, H., Chen, S., Zhang, H., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17596 · Cited by 4
Jin, B., Zhang, Y.-Y., & Pan, J. (2023) · PubMed Central · doi:10.12182/20230560301 · Cited by 4
Dual blockade of IL-6 and CTLA-4 regresses pancreatic tumors in a CD4 + T cell-dependent mannerPreprint
Ware, M. B., McQuinn, C. W., Zaidi, M. Y., Knochelmann, H. M., Mace, T. A., Chen, Z., Zhang, C., Farren, M. R., Ruggieri, A. N., Bowers, J. S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.07.939199 · Cited by 3
Chen, I. M., Donia, M., Chamberlain, C. A., Jensen, A. W. P., Draghi, A., Theile, S., Madsen, K. S., Hasselby, J. P., Toxværd, A., Høgdall, E. V. S., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4165619 · Cited by 4
Loss of TRPV4 reduces pancreatic cancer growth and metastasis
Romac, J. M.-J., Swain, S. M., Mullappilly, N., Bindhani, B., & Liddle, R. A. (2025) · JCI Insight · doi:10.1172/jci.insight.196280 · Cited by 7
You, Y., Feng, Z., Lu, J., Xu, J., You, K., Liu, F., Wu, T., Song, H., & Liu, Z. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00897b · Cited by 4
Luo, W., Hsu, W.-L., Lu, C.-Y., Chien, M.-H., Chang, J., & Su, K. (2024) · Cell Biology and Toxicology · doi:10.1007/s10565-024-09978-y · Cited by 3
Yin, Y., Luo, Y., & He, K. (2023) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2023.01.032 · Cited by 3
Dong, P. H., Zhao, L., Zhao, L., Zhang, J., Lu, G., Zhang, H., & Ma, M. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-214 · Cited by 3
Characterization of the genomic landscape in liver oligometastatic NSCLC
Liao, R., Yi, G., Shen, L., Xiao, X., Zeng, C., Liu, L., Tang, H., Huang, S., Zhang, X., Xu, Z., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-13478-5 · Cited by 3
Wang, L., Sun, Y., Yi, M., Zhao, W., & Yuan, X. (2020) · Oncology Letters · doi:10.3892/ol.2020.11525 · Cited by 3
Tanaka, R., Kageyama, K., Kimura, K., Eguchi, S., Tauchi, J., Shinkawa, H., Ohira, G., Yamazoe, S., Yamamoto, A., Tanaka, S., et al. (2020) · Anticancer Research · doi:10.21873/anticanres.14234 · Cited by 3
CCRK—a hub for liver metastasis and cancer
Low, J.-T., Lin, G., & Chan, M. W. Y. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00569-5 · Cited by 3
Braking the cell’s cycle and invigorating T-cell immunity against pancreatic cancer
Lesinski, G. B. (2020) · Gut · doi:10.1136/gutjnl-2020-321497 · Cited by 3
Link, J. M., Pelz, C., Worth, P. J., Owen, S., Keith, D., Langer, E. M., Grossblatt-Wait, A., Creason, A., Egger, J., Holly, H. D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.04.490552 · Cited by 3
Colorectal cancer liver metastases: immune environment and therapeutic perspectives
Wen, J., Jiang, J., Zhang, J., Wu, Z., Hu, D. X., Wang, W., Zhang, Z., & Xia, L. (2025) · Gastrointestinal Tumors · doi:10.48130/git-0025-0002 · Cited by 2
Vornicu, V.-N., Negru, A. G., Vonica, R. C., Cosma, A. A., Săftescu, S., Fenesan, M. P., & Cîmpean, A. M. (2025) · Medicina · doi:10.3390/medicina61091521 · Cited by 2
The lethal symbiont: exploring the pathophysiology of cancer
Nolan, E., Li, L., Giampazolias, E., Ombrato, L., & Malanchi, I. (2026) · Physiological Reviews · doi:10.1152/physrev.00019.2025 · Cited by 2
Interleukin 6 Drives Durable T Cell-Mediated Immunity to Pancreatic Cancer
Arneson‐Wissink, P. C., Bartlett, A. Q., Mendez, H., Zhu, X., Levasseur, P. R., Diba, P., Murthy, N. T. V., Dickie, J., McWhorter, M., Jozić, A., et al. (2026) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2026.101768 · Cited by 2
Metadata
- Authors
- Lee, J. W., Stone, M. L., Porrett, P. M., Thomas, S. K., Komar, C. A., Li, J. H., Delman, D., Graham, K., Gladney, W. L., Hua, X., Black, T. A., Chien, A. L., Majmundar, K. S., Thompson, J. C., Yee, S. S., O’Hara, M. H., Aggarwal, C., Xin, D., Shaked, A., Gao, M., Liu, D., Borad, M. J., Ramanathan, R. K., Carpenter, E. L., Ji, A., de Beer, M. C., de Beer, F. C., Webb, N. R., & Beatty, G. L.
- Affiliations
- Abramson Cancer Center (US)
- University of Pennsylvania (US)
- University of Georgia (US)
- Mayo Clinic Comprehensive Cancer Center (Arizona) (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- University of Kentucky (US)
- Corresponding author
- Beatty, Gregory L.
- ORCID
- Lee, Jae W.
- Stone, Meredith L.
- Porrett, Paige M.
- Thomas, Stacy K.
- Li, Joey H.
- Graham, Kathleen
- Gladney, Whitney L.
- Chien, Austin L.
- Thompson, Jeffrey C.
- Yee, Stephanie S.
- O’Hara, Mark H.
- Aggarwal, Charu
- Xin, Dong
- Shaked, Abraham
- Gao, Mingming
- Liu, Dexi
- Borad, Mitesh J.
- Carpenter, Erica L.
- Ji, Ailing
- de Beer, Maria C.
- de Beer, Frederick C.
- Webb, Nancy R.
- Beatty, Gregory L.
- Venue
- Nature
- Published
- 2019-03-06
- Volume
- 567
- Issue
- 7747
- Pages
- 249-252
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6430113
- OpenAlex
- W2919508314
- Cited by
- 402
- References
- 41
- Citations by year
- 2026: 30 · 2025: 55 · 2024: 55 · 2023: 64 · 2022: 54 · 2021: 58 · 2020: 57 · 2019: 26
- FWCI
- 20.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- University of Pennsylvania
- National Heart, Lung, and Blood Institute (R01HL134731, T32HL007439)
- National Cancer Institute (T32CA009140, F30CA196106, R01CA197916, P30CA016520)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK050306)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- liver metastasis, hepatocytes, STAT3 signaling, serum amyloid A, interleukin-6, pancreatic cancer, colorectal cancer, liver fibrosis, tumor microenvironment, metastatic tropism
- MeSH terms
- Serum Amyloid A Protein, Animals, Female, Liver, Liver Neoplasms, Male, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms, Interleukin-6, Carcinoma, Pancreatic Ductal, Hepatocytes, STAT3 Transcription Factor, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
